Qualität

Eigenschaften

Molare Masse 219.17

CAS RN [204977-05-9]([¹⁸F]FETNIM)

Reinheit ≥ 95 %

• Colorless solid

Zertifikate

CoA: appearance, ¹H and ¹⁹F NMR spectra

Literatur

Yang D.J. et al. Development of F-18-labeled Fluoroerythro-nitroimidazole as a PET agent for imaging Tumor Hypoxia. Radiology 1995, 194, 795–800.

Grönroos T. et al. Pharmacokinetics of [¹⁸F]FETNIM, A Potential Hypoxia Marker for PET. J. Nucl. Med. 2001, 42, 1397–1404.

Lethiö K. et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59, 971–982.